Carlo Sistilli insider trades
Open-market stock purchases and sales by Carlo Sistilli, Director at Edesa Biotech, Inc, from SEC Form 4 filings since Jan 8, 2020.
Track record: 100% of 3 scored buys are up 5% or more since purchase, averaging +28%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| May 27, 2026 | EDSA Edesa Biotech, Inc | Bought (not open market) | — |
Companies traded
- EDSA Edesa Biotech, Inc: 3 buys, last May 27, 2026